NCT00710463

Brief Summary

Hypothesis: Hospital based, comprehensive pulmonary rehabilitation of patients with COPD in GOLD stage IV can be optimized by application of nocturnal non invasive ventilation. This hypotheses shall be tested by an observational trial, comparing rehabilitation effects of a prospectively observed group receiving non invasive ventilation, compared wiht a historical control group of patients who did received the same treatment without non invasive ventilation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started May 2003

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2003

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2007

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2007

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

July 2, 2008

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 4, 2008

Completed
Last Updated

July 4, 2008

Status Verified

July 1, 2008

Enrollment Period

4.3 years

First QC Date

July 2, 2008

Last Update Submit

July 3, 2008

Conditions

Keywords

COPDnon invasive ventilationpulmonary rehabilitation

Outcome Measures

Primary Outcomes (1)

  • six minute walk distance

    beginning to end of rehabilitation

Secondary Outcomes (1)

  • quality of life

    beginning to end of rehabilitation

Study Arms (2)

Control group

patients receive a hospital based comprehensive pulmonary rehabilitation programme, including endurance training, physiotherapy, medical therapy, and long term oxygen treatment when indicated.

NIV treatment group

patients receive a hospital based comprehensive pulmonary rehabilitation programme, including endurance training, physiotherapy, medical therapy, and long term oxygen treatment when indicated, plus newly introduced nocturnal non invasive ventilation.

Device: non invasive ventilation (Resmed VPAP III ST-A, Respironics Harmony)

Interventions

non invasive ventilation was performed with commercially available ventilators from the manufacturers Resmed and Respironics.

Also known as: Resmed VPAP III ST-A, Respironics Harmony
NIV treatment group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All patients were recruited at a single center, the rehabilitation hospital "Klinikum Berchtesgadener Land" at Germany. Patients entering the well defined, hospital based pulmonary rehabilitation programme after Januar 1, 2005 were additionally treated with nocturnal non invasive ventilation. The results of these patients were compared with a group of patients who underwent the same rehabilitation programme in the years 2003 to 2005, when non invasive ventilation was not availabe.

You may qualify if:

  • Confirmed diagnosis of COPD in stages GOLD IV
  • Receiving optimized medical treatment and long term oxygen treatment, if indicated
  • Patient's consent to participate in this trial

You may not qualify if:

  • Previous treatment with NIPPV
  • Unwillingness or intolerance to perform NIPPV
  • Acute exacerbation of COPD at baseline or during pulmonary rehabilitation,
  • Significant orthopaedic or neurologic problems that reduce mobility or cooperation with physical training
  • Poor controlled coexisting psychiatric or unstable cardiac disease,
  • Inability to perform a six minute walk test
  • Extreme hypercapnia (pCO2 \> 74 mmHg)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Klinikum Berchtesgadener Land

Berchtesgaden, D-83471, Germany

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

Noninvasive Ventilation

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Respiration, ArtificialAirway ManagementTherapeuticsRespiratory Therapy

Study Officials

  • Klaus Kenn, MD

    Klinikum Berchtesgadener Land

    STUDY DIRECTOR
  • Ursula Schönheit-Kenn, ME

    Klinikum Berchtesgadener Land

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Sponsor Type
OTHER

Study Record Dates

First Submitted

July 2, 2008

First Posted

July 4, 2008

Study Start

May 1, 2003

Primary Completion

September 1, 2007

Study Completion

November 1, 2007

Last Updated

July 4, 2008

Record last verified: 2008-07

Locations